These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30381742)

  • 1. Chicken novel leukocyte immunoglobulin-like receptor subfamilies B1 and B3 are transcriptional regulators of major histocompatibility complex class I genes and signaling pathways.
    Truong AD; Hong Y; Lee J; Lee K; Tran HTT; Dang HV; Nguyen VK; Lillehoj HS; Hong YH
    Asian-Australas J Anim Sci; 2019 May; 32(5):614-628. PubMed ID: 30381742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and functional analyses of novel chicken leukocyte immunoglobulin-like receptor subfamily B members 4 and 5.
    Truong AD; Hong Y; Tran HTT; Dang HV; Nguyen VK; Pham TT; Lillehoj HS; Hong YH
    Poult Sci; 2019 Dec; 98(12):6989-7002. PubMed ID: 31376355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular identification and characterisation of a novel chicken leukocyte immunoglobulin-like receptor A5.
    Truong AD; Hong Y; Nguyen HT; Nguyen CT; Chu NT; Tran HTT; Dang HV; Lillehoj HS; Hong YH
    Br Poult Sci; 2021 Feb; 62(1):68-80. PubMed ID: 32812773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte Immunoglobulin-Like Receptors A2 and A6 are Expressed in Avian Macrophages and Modulate Cytokine Production by Activating Multiple Signaling Pathways.
    Truong AD; Rengaraj D; Hong Y; Tran HTT; Dang HV; Nguyen VK; Lillehoj HS; Hong YH
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30208630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory leukocyte immunoglobulin-like receptors in cancer development.
    Zhang F; Zheng J; Kang X; Deng M; Lu Z; Kim J; Zhang C
    Sci China Life Sci; 2015 Dec; 58(12):1216-25. PubMed ID: 26566804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of leukocyte immunoglobulin-like receptor subfamily B expression on immune cells in hepatocellular carcinoma.
    Fan J; Li J; Han J; Zhang Y; Gu A; Song F; Duan J; Yin D; Wang L; Yi Y
    Mol Immunol; 2021 Aug; 136():82-97. PubMed ID: 34098344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors.
    Kang X; Kim J; Deng M; John S; Chen H; Wu G; Phan H; Zhang CC
    Cell Cycle; 2016; 15(1):25-40. PubMed ID: 26636629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-dependent modulation of the expression of MHC class I and MHC class II genes in chicken HD11 cells.
    Truong AD; Hong Y; Ly VD; Nguyen HT; Nguyen CT; Vu HT; Chu NT; Van Hoang T; Thanh Tran HT; Dang HV; Hong YH
    Dev Comp Immunol; 2020 Sep; 110():103729. PubMed ID: 32387556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
    Yusa S; Catina TL; Campbell KS
    J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-34 Regulates Th1 and Th17 Cytokine Production by Activating Multiple Signaling Pathways through CSF-1R in Chicken Cell Lines.
    Truong AD; Hong Y; Lee J; Lee K; Kil DY; Lillehoj HS; Hong YH
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29874806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy.
    Barkal AA; Weiskopf K; Kao KS; Gordon SR; Rosental B; Yiu YY; George BM; Markovic M; Ring NG; Tsai JM; McKenna KM; Ho PY; Cheng RZ; Chen JY; Barkal LJ; Ring AM; Weissman IL; Maute RL
    Nat Immunol; 2018 Jan; 19(1):76-84. PubMed ID: 29180808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The AP-1 transcription factor JunD activates the leukocyte immunoglobulin-like receptor 1 distal promoter.
    Davidson CL; Cameron LE; Burshtyn DN
    Int Immunol; 2014 Jan; 26(1):21-33. PubMed ID: 24038602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MHC class I-LILRB1 signalling axis as a promising target in cancer therapy.
    Zhao J; Zhong S; Niu X; Jiang J; Zhang R; Li Q
    Scand J Immunol; 2019 Nov; 90(5):e12804. PubMed ID: 31267559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonistic anti-LILRB1 monoclonal antibody regulates antitumor functions of natural killer cells.
    Chen H; Chen Y; Deng M; John S; Gui X; Kansagra A; Chen W; Kim J; Lewis C; Wu G; Xie J; Zhang L; Huang R; Liu X; Arase H; Huang Y; Yu H; Luo W; Xia N; Zhang N; An Z; Zhang CC
    J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32771992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Entropically driven MHC class I recognition by human inhibitory receptor leukocyte Ig-like receptor B1 (LILRB1/ILT2/CD85j).
    Shiroishi M; Kuroki K; Tsumoto K; Yokota A; Sasaki T; Amano K; Shimojima T; Shirakihara Y; Rasubala L; van der Merwe PA; Kumagai I; Kohda D; Maenaka K
    J Mol Biol; 2006 Jan; 355(2):237-48. PubMed ID: 16305801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and functional analyses of a novel chicken CD8α variant X1 (CD8α1).
    Truong AD; Ban J; Park B; Hong YH; Lillehoj HS
    J Anim Sci; 2016 Jul; 94(7):2737-51. PubMed ID: 27482661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of signal transducer and activator of transcription 1 (STAT1) and STAT1-dependent genes by RET/PTC (rearranged in transformation/papillary thyroid carcinoma) oncogenic tyrosine kinases.
    Hwang ES; Kim DW; Hwang JH; Jung HS; Suh JM; Park YJ; Chung HK; Song JH; Park KC; Park SH; Yun HJ; Kim JM; Shong M
    Mol Endocrinol; 2004 Nov; 18(11):2672-84. PubMed ID: 15297606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structures of the four Ig-like domain LILRB2 and the four-domain LILRB1 and HLA-G1 complex.
    Wang Q; Song H; Cheng H; Qi J; Nam G; Tan S; Wang J; Fang M; Shi Y; Tian Z; Cao X; An Z; Yan J; Gao GF
    Cell Mol Immunol; 2020 Sep; 17(9):966-975. PubMed ID: 31273318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
    Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
    Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer.
    Zeller T; Münnich IA; Windisch R; Hilger P; Schewe DM; Humpe A; Kellner C
    Front Immunol; 2023; 14():1240275. PubMed ID: 37781391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.